Difference between revisions of "Derache A, et al, Clin. Infect. Dis. (2019), cited as Ref 37 in DOI: 10.3390/v12020211 (Q10116)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Added reference to claim: DOI Identifier (P138): 10.1093/cid/ciy881, #quickstatements; #temporary_batch_1590434736068)
(‎Added reference to claim: Published In Name String (P102): Clin. Infect. Dis., #quickstatements; #temporary_batch_1590456335858)
 
(7 intermediate revisions by the same user not shown)
Property / PubMed ID
 +
Property / PubMed ID: 30321314 / rank
 +
Normal rank
Property / PubMed ID: 30321314 / reference
 +
Property / Volume
 +
69
Property / Volume: 69 / rank
 +
Normal rank
Property / Volume: 69 / reference
 +
Property / title
 +
Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial (English)
Property / title: Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial (English) / rank
 +
Normal rank
Property / title: Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial (English) / reference
 +
Property / Published In Name String
 +
Clin. Infect. Dis.
Property / Published In Name String: Clin. Infect. Dis. / rank
 +
Normal rank
Property / Published In Name String: Clin. Infect. Dis. / reference
 +

Latest revision as of 01:27, 26 May 2020

Cited in: "Current Trends in Diagnostics of Viral Infections of Unknown Etiology" Viruses; 2020 Feb 14 ; 12 (2)
Language Label Description Also known as
English
Derache A, et al, Clin. Infect. Dis. (2019), cited as Ref 37 in DOI: 10.3390/v12020211
Cited in: "Current Trends in Diagnostics of Viral Infections of Unknown Etiology" Viruses; 2020 Feb 14 ; 12 (2)

    Statements

    Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial (English)